Collectively, these results demonstrate that CY12-RP2 functions as a multifaceted immune modulator, counteracting tumor-induced immunosuppression by both expanding cytotoxic lymphocyte populations across lymphoid compartments and reprogramming the tumor microenvironment to support immune-mediated tumor clearance. The gene discussed is RP2; the disease is neoplasm.